| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.
|
N Engl J Med
|
2001
|
5.33
|
|
2
|
Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans.
|
Nat Med
|
1999
|
4.74
|
|
3
|
Infection of the SCID-hu mouse by HIV-1.
|
Science
|
1988
|
4.37
|
|
4
|
Use of overlapping peptide mixtures as antigens for cytokine flow cytometry.
|
J Immunol Methods
|
2001
|
4.25
|
|
5
|
HIV induces thymus depletion in vivo.
|
Nature
|
1993
|
3.73
|
|
6
|
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis.
|
Nat Med
|
2001
|
3.69
|
|
7
|
Long-term human hematopoiesis in the SCID-hu mouse.
|
J Exp Med
|
1990
|
3.59
|
|
8
|
HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
|
J Virol
|
2008
|
3.36
|
|
9
|
Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse.
|
J Exp Med
|
1993
|
2.81
|
|
10
|
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.
|
Am J Transplant
|
2007
|
2.50
|
|
11
|
Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function.
|
AIDS
|
2001
|
2.47
|
|
12
|
Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA.
|
Proc Natl Acad Sci U S A
|
2002
|
2.46
|
|
13
|
Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1.
|
Nat Med
|
1998
|
2.27
|
|
14
|
Impaired replication of protease inhibitor-resistant HIV-1 in human thymus.
|
Nat Med
|
2001
|
2.13
|
|
15
|
HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo.
|
Immunity
|
1995
|
2.07
|
|
16
|
Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse.
|
J Virol
|
1994
|
1.87
|
|
17
|
Isolation and immunologic characterization of a human. B-lymphocyte-specific, cell surface antigen.
|
J Exp Med
|
1976
|
1.74
|
|
18
|
CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo.
|
J Virol
|
1998
|
1.72
|
|
19
|
Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication.
|
Proc Natl Acad Sci U S A
|
1993
|
1.70
|
|
20
|
Direct evidence for thymic function in adult humans.
|
J Exp Med
|
1999
|
1.70
|
|
21
|
Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent.
|
J Immunol
|
1991
|
1.65
|
|
22
|
CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation.
|
J Immunol
|
1998
|
1.64
|
|
23
|
Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis.
|
J Virol
|
1996
|
1.61
|
|
24
|
Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice.
|
J Exp Med
|
1999
|
1.61
|
|
25
|
Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds.
|
Antimicrob Agents Chemother
|
1996
|
1.54
|
|
26
|
Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry.
|
Antimicrob Agents Chemother
|
1996
|
1.51
|
|
27
|
Two types of Ia-positive T cells. Synthesis and exchange of Ia antigens.
|
J Exp Med
|
1980
|
1.47
|
|
28
|
Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy.
|
J Infect Dis
|
2000
|
1.43
|
|
29
|
T cell turnover in HIV-1 disease.
|
Immunity
|
1997
|
1.35
|
|
30
|
Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
|
J Infect Dis
|
2001
|
1.32
|
|
31
|
Implantation and maintenance of functional human bone marrow in SCID-hu mice.
|
Blood
|
1992
|
1.31
|
|
32
|
Pre-B cells and other possible precursor lymphoid cell lines derived from patients with X-linked agammaglobulinemia.
|
J Exp Med
|
1980
|
1.28
|
|
33
|
Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse.
|
J Immunol
|
1991
|
1.26
|
|
34
|
Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.
|
Virology
|
2001
|
1.23
|
|
35
|
Biogenesis of membrane-bound and secreted immunoglobulins. I. Two distinct translation products of human mu-chain, with identical N-termini and different C-termini.
|
J Exp Med
|
1980
|
1.21
|
|
36
|
Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse.
|
Proc Natl Acad Sci U S A
|
1991
|
1.21
|
|
37
|
Enhanced representation of HL-A antigens on human lymphocytes after mitogenesis induced by phytohemagglutinin or Epstein-Barr virus.
|
Proc Natl Acad Sci U S A
|
1975
|
1.20
|
|
38
|
Lymphoid reconstitution of the human fetal thymus in SCID mice with CD34+ precursor cells.
|
J Exp Med
|
1991
|
1.16
|
|
39
|
Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo.
|
Blood
|
1998
|
1.14
|
|
40
|
Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapy.
|
Clin Infect Dis
|
2000
|
1.14
|
|
41
|
J chain biosynthesis in pre-B cells and other possible precursor B cells.
|
J Exp Med
|
1981
|
1.10
|
|
42
|
Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner.
|
J Infect Dis
|
1991
|
1.07
|
|
43
|
Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv mice.
|
J Exp Med
|
1999
|
1.06
|
|
44
|
Induction of MHC class I expression on immature thymocytes in HIV-1-infected SCID-hu Thy/Liv mice: evidence of indirect mechanisms.
|
J Immunol
|
1999
|
1.03
|
|
45
|
Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv mice.
|
Antimicrob Agents Chemother
|
2000
|
1.03
|
|
46
|
Development of a human thymic organ culture model for the study of HIV pathogenesis.
|
AIDS Res Hum Retroviruses
|
1995
|
1.00
|
|
47
|
Causal relationships between HIV-1 coreceptor utilization, tropism, and pathogenesis in human thymus.
|
AIDS Res Hum Retroviruses
|
2000
|
0.98
|
|
48
|
The immunoglobulin-like structure of human histocompatibility antigens.
|
Fed Proc
|
1976
|
0.97
|
|
49
|
The scid-hu mouse: current status and potential applications.
|
Curr Top Microbiol Immunol
|
1989
|
0.94
|
|
50
|
Human hematolymphoid cells in SCID mice.
|
Curr Opin Immunol
|
1994
|
0.94
|
|
51
|
R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus.
|
J Virol
|
1999
|
0.90
|
|
52
|
Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy.
|
J Infect Dis
|
2001
|
0.89
|
|
53
|
Biogenesis of membrane-bound and secreted immunoglobulins: two primary translation products of the human delta chain, differentially N-glycosylated to four discrete forms in vivo and in vitro.
|
Proc Natl Acad Sci U S A
|
1981
|
0.89
|
|
54
|
Indirect induction of radiation lymphomas in mice. Evidence for a novel, transmissible leukemogen.
|
J Exp Med
|
1987
|
0.88
|
|
55
|
Variations in the heme oxygenase-1 microsatellite polymorphism are associated with plasma CD14 and viral load in HIV-infected African-Americans.
|
Genes Immun
|
2011
|
0.86
|
|
56
|
Inhibition of human immunodeficiency virus type 1 infection in SCID-hu Thy/Liv mice by the G-quartet-forming oligonucleotide, ISIS 5320.
|
Antimicrob Agents Chemother
|
1998
|
0.85
|
|
57
|
Ig biosynthesis in a human pre-B cell line.
|
J Immunol
|
1981
|
0.85
|
|
58
|
Coinfection of SCID-hu Thy/Liv mice with human herpesvirus 6 and human immunodeficiency virus type 1.
|
J Virol
|
2000
|
0.85
|
|
59
|
Superantigen-mediated deletion of specific T cell receptor V beta subsets in the SCID-hu Thy/Liv mouse is induced by staphylococcal enterotoxin B, but not HIV-1.
|
J Immunol
|
1997
|
0.84
|
|
60
|
A membrane-bound Fas decoy receptor expressed by human thymocytes.
|
J Biol Chem
|
2000
|
0.82
|
|
61
|
Direct evaluation of radiation damage in human hematopoietic progenitor cells in vivo.
|
Radiat Res
|
1994
|
0.81
|
|
62
|
Biogenesis of membrane-bound and secreted immunoglobulins. II. Two forms of the human alpha chain translated in vitro and processed in vivo as distinct polypeptide chains.
|
J Exp Med
|
1981
|
0.81
|
|
63
|
Human neural xenografts: progress in developing an in-vivo model to study human immunodeficiency virus (HIV) and human cytomegalovirus (HCMV) infection.
|
Adv Neuroimmunol
|
1994
|
0.78
|
|
64
|
Fas is expressed early in human thymocyte development but does not transmit an apoptotic signal.
|
J Immunol
|
1999
|
0.77
|
|
65
|
UV irradiation of polystyrene pipets releases PCR inhibitors.
|
Biotechniques
|
1998
|
0.76
|
|
66
|
Today's SCID-hu mouse.
|
Nature
|
1990
|
0.76
|
|
67
|
Pseudotypes in HIV-infected mice.
|
Science
|
1990
|
0.76
|
|
68
|
Epstein-Barr virus associated lymphoproliferative disease in mice and men.
|
Lab Invest
|
1991
|
0.75
|
|
69
|
Literature watch. Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation.
|
Lymphat Res Biol
|
2006
|
0.75
|
|
70
|
Furry flasks?
|
Nat Biotechnol
|
1998
|
0.75
|
|
71
|
The diversity of T cells.
|
N Engl J Med
|
2001
|
0.75
|